Profiel
Michael Schaefer is currently the Director at 2cureX ApS since 2022.
Prior to this, he was the Co-Managing Director at Sysmex Europe SE and the Executive Vice President at Sysmex Corp.
He also served as an Independent Director at 2cureX AB from 2022 to 2024.
Actieve functies van Michael Schaefer
| Bedrijven | Functie | Begin |
|---|---|---|
2cureX ApS
 2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Directeur/Bestuurslid | 01-01-2022 |
Eerdere bekende functies van Michael Schaefer
| Bedrijven | Functie | Einde |
|---|---|---|
| 2CUREX AB | Directeur/Bestuurslid | 04-01-2024 |
| SYSMEX CORPORATION | Corporate Officer/Principal | - |
Sysmex Europe SE
 Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| SYSMEX CORPORATION | Health Technology |
| 2CUREX AB | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
Sysmex Europe SE
Sysmex Europe SE Medical SpecialtiesHealth Technology Sysmex Europe GmbH designs and produces diagnostic solutions for medical laboratories. It offers diagnostics for haematology, urinalysis, coagulation, moleculat siagnostics, digital imaging, reagent production and veterinary solutions. It also provides solutions for optimized cancer management, sentinel lymph node analysis, and localization, patient care, faecal immunochemical test for haemoglobin, digital pathology and blood-based molecular testing. The company was founded in 1980 and is headquartered in Nordertstedt, Germany. | Health Technology |
